Clinical trial
Clinical Study for the Validation of the Medical Device Mjn-SERAS for the Detection and Prediction of Epileptic Seizures in Individuals from 12 to 65 Years, Suffering from Drug-resistant Epilepsy During Their Day-to-day Activity, to Find Out the Impact of the Digital Solution in the Quality of Life in a Normalised Environment and Provide Valuable Information from Real-World Data.
NCT05845255 is registered in ClinicalTrials.gov with MJN Neuroserveis, S.L as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study for the Validation of the Medical Device Mjn-SERAS for the Detection and Prediction of Epileptic Seizures in Individuals from 12 to 65 Years, Suffering from Drug-resistant Epilepsy During Their Day-to-day Activity, to Find Out the Impact of the Digital Solution in the Quality of Life in a Normalised Environment and Provide Valuable Information from Real-World Data.
- Lead sponsor
- MJN Neuroserveis, S.L
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2023
- Completion date
- June 30, 2025
- Enrollment
- 130 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy (treatment refractory), quality of life